Stress hyperglycemia ratio is linked with lower cognitive function in older patients with diabetes or prediabetes (β: -0.26, 95% CI: -0.39 to -0.12).
“compared to the second quartile, the first [β: -0.26; 95% confidence interval (CI): -0.39- -0.12], third (β: -0.13, 95% CI: -0.25- -0.02), and fourth (β: -0.21, 95% CI: -0.36- -0.06) quartiles were all associated with a decrease in Z-score”
Humansin older patients with diabetes or prediabetes
Stress hyperglycemia ratio was not clearly linked with mortality prediction performance in humans (Compared with triglyceride-glucose index in critically ill patients with heart failure).
“no statistically significant difference was observed in the predictive performance of SHR and TyG index for mortality at any time points (P>0.05).”
HumansCompared with triglyceride-glucose index in critically ill patients with heart failure30, 90, 180, and 365 daysn = 1,063
Stress hyperglycemia ratio is linked with worse gait speed in humans (frail older adults with HFpEF and MoCA < 26) (0.65 ± 0.20 m/s vs. 0.72 ± 0.20 m/s, p = 0.0004).
“Patients with SHR > 1 demonstrated significantly reduced physical performance compared with those with SHR ≤ 1 (mean gait speed 0.65 ± 0.20 m/s vs. 0.72 ± 0.20 m/s, p = 0.0004).”
Humansfrail older adults with HFpEF and MoCA < 26n = 204
Stress hyperglycemia ratio is linked with a higher risk of mortality in humans (STEMI patients harboring common-CHIP undergoing primary percutaneous coronary intervention) (HR 1.84).
“elevated SHR itself was an independent risk factor for mortality, specifically in patients harboring common-CHIP or TET2 mutations (HR=1.84 and 1.83, respectively).”
Stress hyperglycemia ratio predicts mortality in humans (hip fractures) (OR=6.944, 95% CI 2.584 to 18.659).
“Multivariate logistic regression analysis showed that SHR (p<0.001, OR=6.944, 95% CI 2.584 to 18.659) was an independent risk factor for 28-day all-cause mortality.”
Stress hyperglycemia ratio is linked with a higher risk of mortality in humans (elderly ICU patients with delirium) (68% increase, 95% CI 1.17-2.41, p = 0.0053).
“Each standard deviation (SD) rise in SHR within the ranges of 0.85-1.77 for 28 day mortality and 0.89-1.90 for 365 day mortality corresponded to a 68% increase in 28 day mortality risk”
Stress hyperglycemia ratio is linked with a higher risk of mortality in humans (patients with type 2 diabetes and obesity) (adjusted HR 1.32, P < 0.001).
“participants in the highest SHR tertile exhibited significantly elevated hazard ratios (HRs) compared to the reference tertile, with adjusted HRs of 1.32 for all-cause mortality”
Stress hyperglycemia ratio is linked with a higher risk of mortality in subjects without diabetes (OR 4.31, 95% CI 1.25-14.81).
“At multivariable analysis, the risks of death (OR 4.31, 95% CI 1.25-14.81), of all complications (OR 5.90, 95% CI 2.22-15.71) and of newly developed systemic infections”
Diabetes therapy : research, treatment and education of diabetes and related disorders·
Cardiometabolic multimorbidity
↑upin humans2↓downin humans1HR 1.13
2 studies
Stress hyperglycemia ratio is linked with a higher risk of cardiometabolic multimorbidity in humans (HR 1.13, 95% CI 1.03-1.24).
“Each 1-SD increase in the baseline stress-hyperglycemia ratio was associated with 13% higher fully adjusted cardiometabolic multimorbidity risk (hazard ratio = 1.13, 95% confidence interval = 1.03-1.24, p = 0.013)”
Stress hyperglycemia ratio is linked with a lower risk of cardiometabolic multimorbidity in humans (when SHR is below 0.841) (OR = 0.001 [0.000, 0.004]).
“When SHR is below 0.841, CMM risk decreases as SHR increases (OR = 0.001 [0.000, 0.004])”
Stress hyperglycemia ratio is linked with a higher risk of delirium in humans (surgical or trauma ICU patients) (adjusted OR = 2.79; 95% CI: 1.79-4.35).
“Higher SHR was independently associated with greater odds of delirium (Q4 vs. Q1 adjusted OR = 2.79; 95% CI: 1.79-4.35)”
Stress hyperglycemia ratio is linked with a higher risk of delirium in humans (community-acquired pneumonia) (OR 9.13, 95% CI 4.44-18.96).
“SHR (OR = 9.13, 95% CI 4.44-18.96), NLR (OR = 1.12 per unit, 95% CI 1.06-1.19) and PCT (OR = 1.14 per ng/mL, 95% CI 1.06-1.21) were independent predictors of delirium.”
Stress hyperglycemia ratio is associated with 30-day all-cause mortality in humans (Atrial fibrillation with prediabetes; fully adjusted model) (HR 1.27, 95% CI 0.78–2.07; P = 0.338).
“with no significant association observed in the Pre-DM (HR = 1.27, 95% CI 0.78–2.07, P = 0.338)”
HumansAtrial fibrillation with prediabetes; fully adjusted model30 daysn = 1,156
Stress hyperglycemia ratio predicts 30-day all-cause mortality in humans (Atrial fibrillation with normal glucose regulation; fully adjusted model) (HR 1.88, 95% CI 1.15–3.07).
“high SHR remained an independent risk factor solely in the NGR patients (Hazard Ratio [HR] = 1.88, 95% Confidence Interval [CI] 1.15–3.07, P = 0.011)”
HumansAtrial fibrillation with normal glucose regulation; fully adjusted model30 daysn = 1,388
Stress hyperglycemia ratio is associated with incident cardiometabolic multimorbidity in humans (HR 1.09 per SD increase, 95% CI 1.01–1.18).
“each SD increase in baseline SHR, FI, and SHR-FI was associated with HRs of 1.09 (95% CI, 1.01–1.18), 1.36 (1.26–1.48), and 1.35 (1.26–1.45), respectively.”
HumansBaseline measurement; free of cardiometabolic multimorbidity at baseline; fully adjusted modeln = 6,096
Stress hyperglycemia ratio is associated with probable sarcopenia in humans (low SHR, fully adjusted analysis) (OR 1.51 (95% CI 1.02-2.25), p = 0.040).
“low SHR remained independently associated with probable sarcopenia (OR: 1.51, 95% CI: 1.02-2.25; p = 0.040)”
Stress hyperglycemia ratio is associated with 180-day mortality in humans (Critically ill patients with heart failure; adjusted for confounders) (HR 1.35 at 180 days; 1.26 at 365 days; 1.47 at 90 days; 1.53 at 30 days).
“SHR was significantly associated with an increased risk of 180-day, 365-day, 90-day, and 30-day mortality”
HumansCritically ill patients with heart failure; adjusted for confounders180 daysn = 1,063
Stress hyperglycemia ratio is linked with a higher risk of cancer mortality in humans (patients with type 2 diabetes and obesity) (adjusted HR 1.61, P < 0.001).
High glycation index was associated with increased stroke risk at an adjusted hazard ratio of 1.392, which remained 1.333 after HbA1c adjustment.High glycation index was associated with increased stroke risk at an adjusted hazard ratio of 1.392, which remained 1.333 after HbA1c adjustment.